Rotter V - Search Results

1

Mutant p53 enhances nuclear factor kappaB activation by tumor necrosis factor alpha in cancer cells.

Weisz L, Damalas A, Liontos M, Karakaidos P, Fontemaggi G, Maor-Aloni R, Kalis M, Levrero M, Strano S, Gorgoulis VG, Rotter V, Blandino G, Oren M. Weisz L, et al. Among authors: rotter v. Cancer Res. 2007 Mar 15;67(6):2396-401. doi: 10.1158/0008-5472.CAN-06-2425. Cancer Res. 2007. PMID: 17363555

2

Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutants.

Zalcenstein A, Stambolsky P, Weisz L, Müller M, Wallach D, Goncharov TM, Krammer PH, Rotter V, Oren M. Zalcenstein A, et al. Among authors: rotter v. Oncogene. 2003 Aug 28;22(36):5667-76. doi: 10.1038/sj.onc.1206724. Oncogene. 2003. PMID: 12944915

3

Transactivation of the EGR1 gene contributes to mutant p53 gain of function.

Weisz L, Zalcenstein A, Stambolsky P, Cohen Y, Goldfinger N, Oren M, Rotter V. Weisz L, et al. Among authors: rotter v. Cancer Res. 2004 Nov 15;64(22):8318-27. doi: 10.1158/0008-5472.CAN-04-1145. Cancer Res. 2004. Retraction in: Cancer Res. 2019 Apr 15;79(8):2085. doi: 10.1158/0008-5472.CAN-19-0560 PMID: 15548700 Retracted.

4

Mutant p53 protects cells from 12-O-tetradecanoylphorbol-13-acetate-induced death by attenuating activating transcription factor 3 induction.

Buganim Y, Kalo E, Brosh R, Besserglick H, Nachmany I, Rais Y, Stambolsky P, Tang X, Milyavsky M, Shats I, Kalis M, Goldfinger N, Rotter V. Buganim Y, et al. Among authors: rotter v. Cancer Res. 2006 Nov 15;66(22):10750-9. doi: 10.1158/0008-5472.CAN-06-0916. Cancer Res. 2006. PMID: 17108111

5

Mutant p53 gain-of-function in cancer.

Oren M, Rotter V. Oren M, et al. Among authors: rotter v. Cold Spring Harb Perspect Biol. 2010 Feb;2(2):a001107. doi: 10.1101/cshperspect.a001107. Cold Spring Harb Perspect Biol. 2010. PMID: 20182618 Free PMC article. Review.

6

Modulation of the vitamin D3 response by cancer-associated mutant p53.

Stambolsky P, Tabach Y, Fontemaggi G, Weisz L, Maor-Aloni R, Siegfried Z, Shiff I, Kogan I, Shay M, Kalo E, Blandino G, Simon I, Oren M, Rotter V. Stambolsky P, et al. Among authors: rotter v. Cancer Cell. 2010 Mar 16;17(3):273-85. doi: 10.1016/j.ccr.2009.11.025. Cancer Cell. 2010. PMID: 20227041 Free PMC article.

7

Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer.

Cooks T, Pateras IS, Tarcic O, Solomon H, Schetter AJ, Wilder S, Lozano G, Pikarsky E, Forshew T, Rosenfeld N, Harpaz N, Itzkowitz S, Harris CC, Rotter V, Gorgoulis VG, Oren M. Cooks T, et al. Among authors: rotter v. Cancer Cell. 2013 May 13;23(5):634-46. doi: 10.1016/j.ccr.2013.03.022. Cancer Cell. 2013. PMID: 23680148 Free PMC article.

8

Transcription regulation by mutant p53.

Weisz L, Oren M, Rotter V. Weisz L, et al. Among authors: rotter v. Oncogene. 2007 Apr 2;26(15):2202-11. doi: 10.1038/sj.onc.1210294. Oncogene. 2007. PMID: 17401429 Review.

9

Introduction: p53--the first twenty years.

Oren M, Rotter V. Oren M, et al. Among authors: rotter v. Cell Mol Life Sci. 1999 Jan;55(1):9-11. doi: 10.1007/s000180050265. Cell Mol Life Sci. 1999. PMID: 10065147 Free PMC article. Review.

10

Transcriptional programs following genetic alterations in p53, INK4A, and H-Ras genes along defined stages of malignant transformation.

Milyavsky M, Tabach Y, Shats I, Erez N, Cohen Y, Tang X, Kalis M, Kogan I, Buganim Y, Goldfinger N, Ginsberg D, Harris CC, Domany E, Rotter V. Milyavsky M, et al. Among authors: rotter v. Cancer Res. 2005 Jun 1;65(11):4530-43. doi: 10.1158/0008-5472.CAN-04-3880. Cancer Res. 2005. PMID: 15930270

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

307 results

Search Page

Filters